CLINICAL_TRIALS
trial_result
· 2020-02-17
Clinical Trial Update: Phase I/II Thymus Transplantation With Immunosuppression #950 [Phase 1, Phase 2]
Summary
Phase I/II thymus transplantation with immunosuppression completed for DiGeorge anomaly, with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma Switzerland GmbH | Conditions: DiGeorge Anomaly, Complete DiGeorge Anomaly | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-02-17